Who we are

As Corporate Venture Capital unit, we play a strategic role in Evonik’s goal to become a best-in-class specialty chemicals company.

Evonik Venture Capital generates strategic value and growth opportunities through investing and partnering with innovative start-up companies. With a fund size of €250 million, Evonik Venture Capital has made more than 30 investments since 2012, both direct and fund investments. The investment scope ranges from early stage to growth stage with an investment volume of up to €15 million per portfolio company.

Evonik Venture Capital has offices in Germany, the USA and China and invests in innovative technologies and disruptive business models in the fields of Nutrition & Care, Specialty Additives and Smart Materials, as well as enabling digital technologies.

You are looking for a strong partner that provides mentorship and guidance to support your growth path and acts as sparring partner?

The cooperation with Evonik will give you access to a broad network of potential customers, technology experts and other business partners. We are a strategic investor that will actively collaborate with you and will provide strategic, technical and commercial expertise and proficiency.